Q1 saw 19.5% organic revenue growth and a 16.1% EBIT margin, driven by strong performance in Endoscopy Solutions and Anesthesia/Patient Monitoring. Guidance for the year was raised, with new product launches and operational efficiencies supporting future growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.